Education
About Us
Working with TipRanks
Follow Us
Diagonal Bio AB (DE:9F1)
:9F1
9F1 Stock Chart & Stats
€0.10
€0.01(47.83%)
At close: 4:00 PM EST
€0.10
€0.01(47.83%)
Day’s Range― - ―
52-Week Range€0.10 - €0.10
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€604.06K
Enterprise Value€8.75M
Total Cash (Recent Filing)€1.73M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta5.65
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,639,322,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
9F1 FAQ
What was Diagonal Bio AB’s price range in the past 12 months?
Diagonal Bio AB lowest stock price was €0.10 and its highest was €0.10 in the past 12 months.
What is Diagonal Bio AB’s market cap?
Diagonal Bio AB’s market cap is €604.06K.
When is Diagonal Bio AB’s upcoming earnings report date?
Diagonal Bio AB’s upcoming earnings report date is Mar 27, 2026 which is in 104 days.
How were Diagonal Bio AB’s earnings last quarter?
Diagonal Bio AB released its earnings results on Oct 31, 2025. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is Diagonal Bio AB overvalued?
According to Wall Street analysts Diagonal Bio AB’s price is currently Overvalued.
Does Diagonal Bio AB pay dividends?
Diagonal Bio AB does not currently pay dividends.
What is Diagonal Bio AB’s EPS estimate?
Diagonal Bio AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagonal Bio AB have?
Diagonal Bio AB has 1,639,322,000 shares outstanding.
What happened to Diagonal Bio AB’s price movement after its last earnings report?
Diagonal Bio AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Diagonal Bio AB?
Currently, no hedge funds are holding shares in DE:9F1
Company Description
Diagonal Bio AB
Diagonal Bio AB is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral.
Technical Analysis
Stayble Therapeutics AB
―
LIDDS AB
―
CombiGene AB
―
Fluicell AB
―
QuiaPEG Pharmaceuticals Holding AB
―